Answers are grounded in this paper and cite their sources.
Real-world evaluation shows significant improvements in depressive symptoms among patients with treatment-resistant depression following esketamine treatment.
Among patients with TRD treated with esketamine in real-world settings, significant improvements in depressive symptoms were observed over the six months following treatment initiation.
No takes yet. Share an insight, caveat, or question.
MARCI et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: